Name | Number of supported studies | Average coverage | |
---|---|---|---|
lung | 19 studies | 54% ± 18% | |
peripheral blood | 18 studies | 42% ± 12% | |
brain | 16 studies | 33% ± 14% | |
intestine | 12 studies | 51% ± 17% | |
eye | 10 studies | 41% ± 18% | |
kidney | 9 studies | 51% ± 11% | |
liver | 6 studies | 44% ± 18% | |
pancreas | 5 studies | 71% ± 26% | |
placenta | 5 studies | 50% ± 25% | |
bone marrow | 5 studies | 27% ± 8% | |
uterus | 5 studies | 60% ± 21% | |
prostate | 5 studies | 48% ± 19% | |
lymph node | 5 studies | 45% ± 12% | |
skin | 4 studies | 38% ± 19% | |
adipose | 4 studies | 30% ± 10% | |
breast | 4 studies | 60% ± 7% | |
heart | 3 studies | 26% ± 5% | |
adrenal gland | 3 studies | 44% ± 5% | |
esophagus | 3 studies | 55% ± 25% | |
thymus | 3 studies | 51% ± 15% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
breast | 100% | 13907.59 | 459 / 459 | 100% | 129.40 | 1118 / 1118 |
esophagus | 100% | 11031.87 | 1445 / 1445 | 100% | 79.25 | 183 / 183 |
liver | 100% | 8103.60 | 226 / 226 | 100% | 86.37 | 406 / 406 |
lung | 100% | 13045.31 | 578 / 578 | 100% | 102.18 | 1155 / 1155 |
ovary | 100% | 11119.36 | 180 / 180 | 100% | 107.27 | 430 / 430 |
pancreas | 100% | 8770.91 | 328 / 328 | 100% | 122.23 | 178 / 178 |
prostate | 100% | 11672.50 | 245 / 245 | 100% | 168.51 | 502 / 502 |
stomach | 100% | 12102.09 | 359 / 359 | 100% | 91.02 | 286 / 286 |
uterus | 100% | 11891.91 | 170 / 170 | 100% | 98.45 | 459 / 459 |
brain | 100% | 9264.12 | 2639 / 2642 | 100% | 83.35 | 705 / 705 |
thymus | 100% | 14604.52 | 653 / 653 | 100% | 141.42 | 603 / 605 |
kidney | 100% | 13099.85 | 89 / 89 | 100% | 100.69 | 898 / 901 |
intestine | 100% | 13777.12 | 966 / 966 | 100% | 98.76 | 525 / 527 |
bladder | 100% | 11477.14 | 21 / 21 | 100% | 98.85 | 502 / 504 |
skin | 100% | 11448.53 | 1809 / 1809 | 99% | 92.55 | 467 / 472 |
adrenal gland | 100% | 15571.67 | 258 / 258 | 99% | 111.82 | 227 / 230 |
adipose | 100% | 12737.02 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 14611.36 | 1335 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 46.04 | 29 / 29 |
muscle | 100% | 7304.72 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 9456.17 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 80.13 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 27.90 | 1 / 1 |
heart | 98% | 9225.66 | 846 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 96% | 7857.76 | 894 / 929 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 90% | 49.03 | 72 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_1903077 | Biological process | negative regulation of protein localization to plasma membrane |
GO_0006914 | Biological process | autophagy |
GO_0010508 | Biological process | positive regulation of autophagy |
GO_0006486 | Biological process | protein glycosylation |
GO_0000138 | Cellular component | Golgi trans cisterna |
GO_0000139 | Cellular component | Golgi membrane |
GO_0000137 | Cellular component | Golgi cis cisterna |
GO_0005764 | Cellular component | lysosome |
GO_0070062 | Cellular component | extracellular exosome |
GO_0031902 | Cellular component | late endosome membrane |
GO_0005886 | Cellular component | plasma membrane |
GO_0005765 | Cellular component | lysosomal membrane |
GO_0005770 | Cellular component | late endosome |
GO_0005797 | Cellular component | Golgi medial cisterna |
GO_0004175 | Molecular function | endopeptidase activity |
GO_0005515 | Molecular function | protein binding |
Gene name | TMEM59 |
Protein name | Transmembrane protein 59 Transmembrane protein 59 (Liver membrane-bound protein) |
Synonyms | hCG_33694 HSPC001 C1orf8 UNQ169/PRO195 |
Description | FUNCTION: Acts as a regulator of autophagy in response to S.aureus infection by promoting activation of LC3 (MAP1LC3A, MAP1LC3B or MAP1LC3C). Acts by interacting with ATG16L1, leading to promote a functional complex between LC3 and ATG16L1 and promoting LC3 lipidation and subsequent activation of autophagy . Modulates the O-glycosylation and complex N-glycosylation steps occurring during the Golgi maturation of several proteins such as APP, BACE1, SEAP or PRNP . Inhibits APP transport to the cell surface and further shedding . . |
Accessions | Q5T703 Q5T6Z8 ENST00000371341.5 ENST00000420738.5 ENST00000371337.3 ENST00000234831.10 ENST00000371344.5 Q5T704 ENST00000371348.5 Q5T706 ENST00000452421.5 Q6P5R1 Q9BXS4 ENST00000440019.5 |